# Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254

> **NCT04507321** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 5 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** GSK3640254 Oral tablet
- **DRUG:** [14C]-GSK3640254 intravenous infusion
- **DRUG:** [14C]-GSK3640254 powder

## Key facts

- **NCT ID:** NCT04507321
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-24
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04507321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04507321, "Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04507321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*